Galtipex Solution for Injection

Glatiramer acetate
1 ml
ASPEN HEALTHCARE MALTA LIMITED
Pack size 12 Pre-filled Syringe (1 ml)
Dispensing mode
Source
Agent
Retail Price 322.02 AED

Indications

Galtipex Solution for Injection is used for: For reduction of the frequency of relapses in patients with Relapsing-Remitting Multiple Sclerosis.

Adult Dose

Child Dose

Renal Dose

Administration

Contra Indications

Precautions

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Glatiramer acetate :

Mechanism of Action

Glatiramer acetate (GA) exhibits strong and promiscuous binding to MHC molecules (HLA DRB1* variants) and consequent competition with various myelin antigens for their presentation to T cells. A further aspect of its action is potent induction of specific suppressor cells of the T helper 2 (Th2) type that migrate to the brain and lead to in situ bystander suppression. Furthermore, the GA-specific cells in the brain express the anti-inflammatory cytokines IL-10 and transforming growth factor beta, in addition to brain-derived neurotrophic factor, whereas they do not express the inflammatory cytokine IFN-gamma. Recent evidence also suggests that Glatiramer acetate directly inhibits dendritic cells and monocytes - both of which are circulating antigen presenting cells.

Note

Galtipex 1 ml Solution for Injection manufactured by ASPEN HEALTHCARE MALTA LIMITED. Its generic name is Glatiramer acetate. Galtipex is availble in Saudi Arabia. Farmaco SA drug index information on Galtipex Solution for Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Glatiramer acetate :